Skip to main content

Table 1 Clinical characteristics and laboratory results of patients and healthy volunteers

From: Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?

 

PsA

Healty controls

p value

Age (mean ± SD, years)

49.50 ± 11.86

46.82 ± 5.703

0.356

Female

25 (64.1%)

11 (57.9%)

0.647

Insulin

11.7 (10.18–15.35)

8.6 (6.35–12.40)

0.032

FPG

91 (81.75–111.50)

88 (80.50–91)

0.212

HOMA-IR

2.67 (1.97–4.00)

1.93 (1.31–2.68)

0.043

SAP

40.20 (34.35–72.75)

40.2 (35.15–74.30)

0.920

Total cholesterol

190 (118–308)

190 (173.50–213.50)

0.827

HDL cholesterol

44.50 (34.70–50.75)

45 (37.00–51.50)

0.862

LDL cholesterol

113.50 (87.76–132.25)

126 (118.50–142.50)

0.079

Triglyceride

121.50 (89.75–178)

132 (71.00–166.50)

0.927

TG/HDL

2.97 (1.86–4.53)

3.36 (1.60–3.92)

0.771

AC

3.46 (2.69–4.24)

3.27 (2.41–4.20)

0.743

AIP

0.47 (0.27–0.66)

0.52 (0.20–0.59)

0.771

CRI-1

4.46 (3.67–5.24)

4.27 (3.41–5.20)

0.743

CRI-2

2.71 (2.22–3.05)

2.80 (2.18–3.52)

0.423

Ca-LDL

15.74 (13.52–50.95)

33.38 (13.81–80.08)

0.267

Mean CIMT

0.70 (0.60–0.81)

0.55 (0.53–0.63)

0.003

  1. Results are expressed as median (IQR), mean ± SD or number (%), where appropriate
  2. SD standard deviation, FPG fasting plasma glucose, SAP serum amyloid A protein, AC atherogenic coefficient, AIP atherogenic index of plasma, CRI Castelli’s risk indices, CIMT carotid intima-media thickness
  3. Bold values indicate statistically significant differences